Literature DB >> 18493823

Interleukin-12 receptor beta1 polymorphisms and nontuberculous mycobacterial lung diseases.

Hye Yun Park1, Yong Soo Kwon1, Chang-Seok Ki2, Gee Young Suh1, Man Pyo Chung1, Hojoong Kim1, O Jung Kwon1, Won-Jung Koh3.   

Abstract

The pathway involving interferon-gamma and interleukin (IL)-12 plays an important role in host defense against mycobacterial infections. Recent studies have indicated that IL-12 receptor beta1 (IL-12Rbeta1) gene polymorphisms are associated with susceptibility to pulmonary tuberculosis. However, there have been no reports of an association between IL-12Rbeta1 gene polymorphism and lung disease caused by nontuberculous mycobacteria (NTM). The present study involved 128 patients with the nodular bronchiectatic form of NTM lung disease (75 patients with Mycobacterium avium-intracellulare complex infection and 53 patients with Mycobacterium abscessus infection) and 240 healthy controls. Single nucleotide polymorphisms of the IL-12Rbeta1 gene at positions +705A/G, +1158T/C, and +1196G/C were determined by direct sequencing of polymerase chain reaction products. Comparisons of the NTM lung disease patients with healthy controls did not identify any significant differences in relation to the genotype, allele, and haplotype frequencies of the IL-12Rbeta1 +705A/G, +1158T/C, and +1196G/C polymorphisms. These IL-12Rbeta1 gene polymorphisms do not appear to be responsible for host susceptibility to NTM lung disease, at least in this Korean population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493823     DOI: 10.1007/s00408-008-9096-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  25 in total

Review 1.  Host susceptibility factors in mycobacterial infection. Genetics and body morphotype.

Authors:  Shireen V Guide; Steven M Holland
Journal:  Infect Dis Clin North Am       Date:  2002-03       Impact factor: 5.982

2.  'Racial' differences in genetic effects for complex diseases.

Authors:  John P A Ioannidis; Evangelia E Ntzani; Thomas A Trikalinos
Journal:  Nat Genet       Date:  2004-11-14       Impact factor: 38.330

3.  Lack of an association between interleukin-12 receptor beta1 polymorphisms and tuberculosis in Koreans.

Authors:  Hye Won Lee; Hee Seok Lee; Deog Kyeom Kim; Dong Seok Ko; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  Respiration       Date:  2005 Jul-Aug       Impact factor: 3.580

4.  IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice.

Authors:  T M Doherty; A Sher
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

Review 5.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

Authors:  G Trinchieri
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

6.  Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum.

Authors:  W J Koh; C M Yu; G Y Suh; M P Chung; H Kim; O J Kwon; N Y Lee; M J Chung; K S Lee
Journal:  Int J Tuberc Lung Dis       Date:  2006-09       Impact factor: 2.373

Review 7.  Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

8.  Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: comparison between Mycobacterium avium-intracellulare complex and Mycobacterium abscessus infection.

Authors:  Myung Jin Chung; Kyung Soo Lee; Won-Jung Koh; Ju Hyun Lee; Tae Sung Kim; O Jung Kwon; Seonwoo Kim
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

9.  Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency.

Authors:  Isabel Caragol; Miquel Raspall; Claire Fieschi; Jaqueline Feinberg; María N Larrosa; Manuel Hernández; Concepción Figueras; Jose-María Bertrán; Jean-Laurent Casanova; Teresa Español
Journal:  Clin Infect Dis       Date:  2003-07-07       Impact factor: 9.079

10.  Decreased cytokine production in patients with nontuberculous mycobacterial lung disease.

Authors:  Yong Soo Kwon; Eun Joo Kim; Shin-Hye Lee; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Won-Jung Koh
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

View more
  4 in total

1.  Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease.

Authors:  Poopak Farnia; Jalaledin Ghanavi; Shima Saif; Parissa Farnia; Ali Akbar Velayati
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

3.  Personalized medicine approach in mycobacterial disease.

Authors:  Mehdi Mirsaeidi
Journal:  Int J Mycobacteriol       Date:  2012-06

4.  A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease.

Authors:  Samuel Halstrom; Catherine L Cherry; Michael Black; Rachel Thomson; Hayley Goullee; Svetlana Baltic; Richard Allcock; Suzanna E L Temple; Patricia Price
Journal:  Immunogenetics       Date:  2017-02-23       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.